# Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug

> **NCT00043901** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 141 (actual)

## Conditions studied

- Epilepsy, Tonic-Clonic

## Interventions

- **DRUG:** lamotrigine

## Key facts

- **NCT ID:** NCT00043901
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-12-01
- **Primary completion:** 2003-11-01
- **Final completion:** 2005-03-01
- **Target enrollment:** 141 (ACTUAL)
- **Last updated:** 2017-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00043901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00043901, "Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00043901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*